参考文献/References:
[1] Hundley WG, Bluemke DA, Finn JP,et al.ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance[J].Circulation,2010,121(22):2462-2508.
[2] Krishnamurthy R, Cheong B, Muthupillai R,et al.Tools for cardiovascular magnetic resonance imaging[J].Cardiovasc Diagn Ther,2014,4(2):104-125.
[3] Gibson PH, Becher H, Choy JB,et al.Classification of left ventricular size: diameter or volume with contrast echocardiography?[J].Open Heart,2014,1(1):e000147.
[4] Wince WB, Suranyi P, Schoepf UJ,et al.Contemporary cardiovascular imaging methods for the assessment of at-risk myocardium[J].J Am Heart Assoc,2013,3(1):e000473.
[5] Irwan R, Lubbers DD,van der Vleuten PA,et al.Parallel imaging for first-pass myocardial perfusion[J].Magn Reson Imaging,2007,25(5):678-683.
[6] Ge L, Kino A, Lee D, et al.Myocardial perfusion magnetic resonance imaging using sliding-window conjugate-gradient HYPR methods in canine with stenotic coronary arteries[J].J Comput Assist Tomogr,2010,34:684-688.
[7] Ge L, Kino A, Griswold M, et al.Free-breathing myocardial perfusion MRI using SW-CG-HYPR and motion correction[J].Magn Reson Med,2010,64(4):1148-1154.
[8] Stirrat J, Joncas SX, Salerno M,et al.Influence of phase correction of late gadolinium enhancement images on scar signal quantification in patients with ischemic and non-ischemic cardiomyopathy[J].J Cardiovasc Magn Reson,2015,17(1):66.
[9] Horacek BM, Wang L, Dawoud F, et al.Noninvasive electrocardiographic imaging of chronic myocardial infarct scar[J].J Electrocardiol,2015,48(6):952-958.
[10] Ibrahim T,Bulow HP,Hackl T,et al.Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction[J].J Am Coll Cardiol,2007,49(2):208-216.
[11] Schelbert EB,Cao JJ,Sigurdsson S,et al.Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults[J].JAMA,2012,308(9):890-896.
[12] Michèle H,Georges F,Guillaume N,et al.Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease[J].J Cardiovasc Magn Reson,2010,12:29.
[13] Greenwood JP,Maredia N,Younger JF,et al.Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease(CE-MARC):a prospective trial[J].Lancet,2012,379(9814):453-460.
[14] Jogiya R, Kozerke S, Morton G, et al.Validation of dynamic 3-dimensional whole heart magnetic resonance myocardial perfusion imaging against fractional flow reserve for the detection of significant coronary artery disease[J].JACC,2012,60(8):756-765.
[15] Nagel E,Lehmkuhl HB,Bocksch W,et al.Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI:comparison with dobutamine stress echocardiography[J].Circulation,1999,99(6):763-770.
[16] Wahl A,Paetsch I,Gollesch A,et al.Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia:experience in 1 000 consecutive cases[J].Eur Heart J,2004,25(14):1230-1236.
[17] Kirschbaum SW, Rossi A, van Domburg RT,et al.Contractile reserve in segments with nontransmural infarction in chronic dysfunctional myocardium using low-dose dobutamine CMR[J].JACC Cardiovasc Imaging,2010,3(6):614-622.
[18] Mordi I, Stanton T, Carrick D,et al.Comprehensive dobutamine stress CMR versus echocardiography in LBBB and suspected coronary artery disease[J].JACC Cardiovasc Imaging,2014,7(5):490-498.
[19] Glaveckaite S, Valeviciene N, Palionis D,et al.Prediction of long-term segmental and global functional recovery of hibernating myocardium after revascularisation based on low dose dobutamine and late gadolinium enhancement cardiovascular magnetic resonance[J].J Cardiovasc Magn Reson,2014,16:83.
[20] Rman SV,Simonetti OP,Winner MW,et al.Cardiac magnetic resonance with edema imaging identifies myocardium at risk and predicts worse outcome in patients with non-ST-segment elevation acute coronary syndrome[J].J Am Coll Cardiol,2010,55(22):2480-2488.
[21] Eitel I, Pöss J, Jobs A,et al.Left ventricular global function index assessed by cardiovascular magnetic resonance for the prediction of cardiovascular events in ST-elevation myocardial infarction[J].J Cardiovasc Magn Reson,2015,17:62.
[22] Eitel I,Steffen D,Suzanne W,et al.Long-term prognostic value of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction[J].Heart,2011,97:2038-2045.
[23] Ruder TD, Ebert LC, Khattab AA,et al.Edema is a sign of early acute myocardial infarction on post-mortem magnetic resonance imaging[J].Forensic Sci Med Pathol,2013,9(4):501-505.
[24] Li JH, Yang P, Li AL,et al.The preventive effect of garlicin on a porcine model of myocardial infarction reperfusion no-reflow[J].Chin J Integr Med,2014,20(6):425-429.
[25] Klug G, Mayr A, Schenk S.Prognostic value at 5 years of microvascular obstruction after acute myocardial infarction assessed by cardiovascular magnetic resonance[J].J Cardiovasc Magn Reson,2012,14:46.
[26] Meimoun P, Clerc J, Ghannem M,et al.Non-invasive coronary flow reserve is an independent predictor of exercise capacity after acute anterior myocardial infarction[J].Ann Cardiol Angeiol,2012,61(5):323-330.
[27] Basso C,Corbetti F,Silva C,et al.Morphologic validation of reperfused hemorrhagic myocardial infarction by cardiovascular magnetic resonance[J].Am J Cardiol,2007,100:1322-1327.
[28] van den Bos EJ,Baks T,Moelker AD,et al.Magnetic resonance imaging of haemorrhage within reperfused myocardial infarcts:possible interference with iron oxide-labelled cell tracking?[J].Eur Heart J,2006,27:1620-1626.
[29] Altiok E, Tiemann S, Becker M,et al.Myocardial deformation imaging by two-dimensional speckle-tracking echocardiography for prediction of global and segmental functional changes after acute myocardial infarction:a comparison with late gadolinium enhancement cardiac magnetic resonance[J].J Am Soc Echocardiogr,2014,27(3):249-257.
[30] Shah DJ, Kim HW,James O,et al.Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease[J].JAMA,2013,309(9):909-918.
[31] Roes SD,Kelle S,Kaandorp TA, et al.Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction[J].Am J Cardiol,2007,100(6):930-936.
相似文献/References:
[1]杜钧,佘强.冠心病抗炎治疗的临床研究进展[J].心血管病学进展,2016,(1):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
DU Jun,SHE Qiang.Clinical Research Progress of Anti-inflammatory Therapy of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2016,(2):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
[2]努热曼古丽·阿布都克热木,马依彤.重度左心室收缩功能不全的冠心病患者血运重建治疗疗效及预后的评价[J].心血管病学进展,2016,(1):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
NUREMANGULI·Abudukeremu,MA Yitong.Evaluation of Efficacy and Prognosis of Revascularization Therapy on Patients
with Coronary Heart Disease and Severe Left Ventricular Systolic Dysfunction[J].Advances in Cardiovascular Diseases,2016,(2):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
[3]罗水莲,综述,苏立,等.多层螺旋CT及磁共振成像技术在心房颤动消融术中的应用[J].心血管病学进展,2016,(2):147.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.013]
LUO Shuilian,SU Li.Application of Multislice Computed Tomography and Magnetic Resonance
Imaging in Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(2):147.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.013]
[4]刘洋,综述,伍贵富,等.增强型体外反搏治疗冠心病的新机制[J].心血管病学进展,2016,(2):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
LIU Yang,WU Guifu.New Mechanism of Enhanced External Counterpulsation for
Treatment of Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2016,(2):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
[5]史敬,综述,马依彤,等.n-3多不饱和脂肪酸对心血管疾病的临床应用[J].心血管病学进展,2016,(3):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
SHI Jing,MA Yitong.Effects of n-3 Polyunsaturated Fatty Acids on Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(2):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
[6]宋林声,综述,陆地,等.低剂量多巴酚丁胺负荷磁共振成像在缺血性心脏病中的应用研究[J].心血管病学进展,2016,(3):285.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.018]
SONG Linsheng,LU Di,ZHAO Xinxiang.Low-dose Dobutamine Stress MRI Myocardial Perfusion and
Assessment of Myocardial Viability[J].Advances in Cardiovascular Diseases,2016,(2):285.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.018]
[7]高柳,袁晋青.重复支架置入术治疗药物洗脱支架再狭窄的研究进展[J].心血管病学进展,2015,(5):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
GAO Liu,YUAN Jingqing.Progress in Treatment for Drug-eluting Stent Restenosis by
Re-implementation of Stents[J].Advances in Cardiovascular Diseases,2015,(2):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
[8]邓文政,邓平.MG53蛋白的研究进展[J].心血管病学进展,2015,(5):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
DENG Wenzheng,DENG Ping.Research Progress of MG53[J].Advances in Cardiovascular Diseases,2015,(2):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
[9]陈静,李兴德.冠心病患者服药依从性的研究进展[J].心血管病学进展,2015,(6):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
CHEN Jing,LI Xingde.Advances in Medication Adherence of Patients with Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2015,(2):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
[10]姚雯,毛露,孙硕,等.心源性外泌体作为冠心病标志物和新靶点展望[J].心血管病学进展,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
YAO Wen,MAO Lu,SUN Shuo,et al.Exogenous Exosome as A New Marker and Target of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(2):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]